Air Liquide Joins ILP

THIS PAGE HAS BEEN FORMATTED FOR EASY PRINTING

CAMBRIDGE, MA, November 8, 2005 - CIMIT is pleased to announce that Air Liquide, Inc., has joined the Industry Liaison Program.

Air Liquide (www.airliquide.com), world leader in industrial and medical gases, is targeting new marketing opportunities in the domain of inhalation therapy. To support this development, the company is initiating a new field of Research and Development that will involve scientific research and clinical applications. It will integrate theoretical and experimental efforts including animal studies and clinical trials.

The company hopes to focus efforts on the use and application of gases as drugs, the development of novel delivery equipment, and getting related approvals. With a goal of expanding internationally, Air Liquide is actively establishing new scientific, clinical and business partnerships in the US and elsewhere. Membership in CIMIT is a major step toward this goal and the company looks forward to powerful collaboration with clinicians and engineers within the CIMIT community.